CBX1 and nasopharyngeal carcinoma: The results showed that cells overexpressing the three mutants had significantly lower m6A levels of CBX1 mRNA compared to those overexpressing the WT construct, supporting that CBX1 was m6A‐modified on the fragment containing those four “A” sites in NPC cells (Figure 1E).